Page last updated: 2024-08-16

tibolone and Menopause

tibolone has been researched along with Menopause in 120 studies

Research

Studies (120)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (10.00)	18.7374
1990's	15 (12.50)	18.2507
2000's	63 (52.50)	29.6817
2010's	29 (24.17)	24.3611
2020's	1 (0.83)	2.80

Authors

Authors	Studies
Abdullahi, LO; Arena, A; Borghese, G; Degli Esposti, E; Manzara, F; Meriggiola, MC; Moro, E; Raimondo, D; Seracchioli, R; Terzano, P; Zanello, M	1
Fait, T	1
Barreto, GE; Del Río, JP; Garcia-Segura, LM; Hidalgo-Lanussa, O; Molina, S	1
Bleeker, C; Gavrilidis, E; Gurvich, C; Hudaib, AR; Kulkarni, J; Thew, C; Thomas, N; Worsley, R	1
Ferriani, RA; Figueiredo, JB; Lara, LA; Martins, WP; Nastri, CO; Rosa-E-Silva, AC	1
Ornelas-Aguirre, JM; Pérez-Nápoles, DE; Zayas-Jaime, FJ	1
Ameye, L; Antoine, C; de Azambuja, E; Paesmans, M; Rozenberg, S	2
Bhattacharya, SM; Ghosh, M	1
Cucinella, L; Nappi, RE	1
Castelo-Branco, C; Currie, H; Mijatovic, V; Nappi, RE; Palacios, S; Rees, M; Simon, J	1
Carneiro, F; Lopes, S; Macedo, G; Peixoto, A; Silva, M; Vilas-Boas, F	1
Baladé Martínez, L; Macías Saint-Gerons, D; Montero Corominas, D	1
Bentolila, J; Boisserie-Lacroix, M; Bouzgarrou, M; Cavagni, P; Laumonier, H; Lebiez-Michel, N; Trillaud, H	1
Dell'aniello, S; Garbe, E; Renoux, C; Suissa, S	1
Goodwin, PJ	1
Nappi, RE; Polatti, F	1
Bevilacqua, E; Brunelli, R; Capri, O; Ceci, F; Ciarla, MV; Galoppi, P; Perrone, G; Strom, R	1
Bonfill, X; Martínez-Pino, I; Puig, T; Quintana, MJ; Solà, J	1
Antsaklis, A; Dimitrakakis, C; Keramopoulos, D; Tsigginou, A	1
Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C	1
Battaglia, D; Cicinelli, E; Lello, S; Maffei, S; Mercuri, A; Vassalle, C	1
Brincat, M; Erel, T; Gambacciani, M; Lambrinoudaki, I; Moen, MH; Rees, M; Rozenberg, S; Schenck-Gustafsson, K; Tremollieres, F; Vujovic, S	1
Köşüş, A; Köşüş, N; Kurtaran, H; Turhan, NÖ	2
Lumsden, MA; Sassarini, J	1
Huang, KE	1
Gray, S	1
Köşüş, A; Köşüş, N; Turhan, NÖ	1
Bárcena-Jacobo, TD; Carranza-Lira, S; Ramos-León, JC; Sandoval-Barragán, MP	1
Chatzigeorgiou, K; Goulis, D; Pantazis, K; Papanicolaou, A; Tarlatzis, BC; Theodoridis, TD; Vavilis, D	1
Bao, W; Bouchard, P; Cheng, RJ; Constantine, G; de Villiers, TJ; Panay, N; Vincendon, P	1
Almeida, M; Azevedo, G; Cavalcanti, MA; Martins, R; Morais-Socorro, M; Neto Francisco, P; Rezende, A	1
Eyster, KM; Hansen, KA	1
Jamin, C; Madelenat, P; Poncelet, C	1
Menendez, C; Palacios, S; Tobar, AC	1
Letonturier, P	1
Metsä-Heikkilä, M; Ylikorkala, O	1
Davis, SR	1
Aktaş, A; Kanik, A; Pata, O; Tot, S; Yazici, A; Yazici, K	1
Arabi, A; Benhamou, CL; Garnero, P; Pelissier, C; Porcher, R; Roux, C	1
Kelly, MW; Swegle, JM	1
Reynir Tomas, G	1
Ringa, V	1
Kenemans, P	1
Anthony, MS; Clarkson, TB; Cline, JM; Ederveen, AG; Lees, CJ	1
Morris, E; Rymer, J	3
Boisserie-Lacroix, M; Boutet, G; Trillaud, H	1
Camli, L; Gülseren, L; Gülseren, S; Kalafat, D; Mandaci, H	1
Aytan, H; Kelekci, S; Mollamahmutoglu, L; Oguz, S; Sargin, A; Tapisiz, OL	1
Mijatovic, V; van der Mooren, MJ; Vogelvang, TE	1
Anderson, GL; Chlebowski, RT	1
Azavedo, E; Carlström, K; Hofling, M; Kloosterboer, H; Svane, G; Von Schoultz, B	1
Kenemans, P; Speroff, L	1
Cheifitz, RL	1
Akgül, C; Canbaz, M; Vural, P	1
Ayas, B; Baksu, A; Baksu, B; Citak, S; Goker, N; Kalan, A	1
Baber, R; Hickey, M; Kwik, M	1
Athayde, C; Correia, T; Coutinho, E; Freitas, LA; Maia, H	1
Liu, JH	1
Demirci, F; Erdogmus, B; Ozdemir, I; Somunkiran, A; Yazici, B	1
Giraldi, AG; Gregersen, N; Hilmand, CB; Jensen, PT	1
Burger, HG	1
Seeley, T	1
Edwards, D; Gibbs, RB; Lazar, N; Nelson, D; Talameh, J	1
Das, K; Naskar, M	1
Bianco, V; Murina, F; Roberti, P; Valente, I	1
Hillard, TC; Soliman, NF	1
Avci, R; Develioğlu, O; Kaymaz, C; Uncu, G; Uncu, Y	1
Giraldi, AE; Gregersen, N; Jensen, PT	1
Ayhan, A; Demirol, A; Gurgan, T; Guven, S; Guvendag Guven, ES; Kirazli, S	1
Antoine, C; Carly, B; Liebens, F; Pastijn, A; Rozenberg, S	1
Albani, F; Chiovato, L; Genazzani, AR; Nappi, RE; Polatti, F; Valentino, V	1
Bai, W; Geng, L; Henneicke-von Zepelin, HH; Hu, L; Jiao, C; Liske, E; Liu, J; Wang, S; Zhang, Z; Zheng, S	1
Green, J; Watson, J; Wise, L	1
Bhattacharya, SM	1
Campisi, R; Marengo, FD	1
Abaurrea Ortiz, MP; Caballero Carrasco, A; Pérez García, VJ; Rangel Tarifa, MJ	1
Carranza-Lira, S; Cuan-Martínez, JR; Rosales-Ortíz, S	1
Erel, CT; Gezer, A; Kaleli, S; Sentürk, LM; Seyisoglu, H; Somunkiran, A	1
Lazovic, G; Marinkovic, J; Radivojevic, U	1
Garefalakis, M; Hickey, M	1
Farish, E; Fletcher, CD; Hart, DM; Leggate, J; Lindsay, R	1
Nevinny-Stickel, J	1
Chryssikopoulos, E; Cortes-Prieto, J; Eydam, F; Franchi, F; Kicovic, PM; Liukko, P; Luisi, M; Milojevic, S; Punnonen, R; Trévoux, R	1
Coope, J	1
Birkhaeuser, MH; Haenggi, W; Riesen, W	1
Chapman, MG; Fogelman, I; Rymer, J	1
Gillmer, MD; Gray, MD; McEwan, HP; Pyper, RJ; Rollason, TP; von Dadelszen, P; Wright, A	1
Wu, YY	1
Chapman, M; Crook, D; Rymer, J; Sidhu, M; Stevenson, JC	1
Argyroudis, EM; Diakakis, I; Georgoulias, N; Giannikos, L; Iatrakis, G; Karamanos, K; Kourkoubas, A; Kourounis, G; Ladopoulos, J; Prapa, Z; Tsionis, C	1
Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V	1
Christau, S; Garre, K; Hammar, M; Nathorst-Böös, J; Rud, T	1
Albertazzi, P; Di Micco, R; Zanardi, E	1
D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V	1
Maroulis, GB	1
Alamo, F; Bartual, E; Herruzo, A; Mendoza, N; Suárez, AM; Vergara, F	1
Morris, EP; Rymer, J	1
Jamin, C	1
Ozşener, S; Oztekin, K; Sendağ, F; Terek, MC	1
Duursma, SA; Meeuwsen, IB; Samson, MM; Verhaar, HJ	1
Doorstam, DP; Timmer, CJ	1
Kopera, H; van Keep, PA	1
Leeuwenkamp, OR; Lips, P; Netelenbos, JC; Schot, LP; Siregar-Emck, MT; van Ginkel, FC	1
Andolsek, L; Benedek-Jaszmann, LJ; Genazzani, AR; Hart, DM; Kicovic, PM; Tax, L	1
Benedek-Jaszmann, LJ; Kicovic, PM; Kloosterboer, HJ	1
Alessandrini, G; Facchinetti, F; Genazzani, AR; Grasso, A; Petraglia, F; Volpe, A	1
Bergamaschi, M; Facchinetti, F; Genazzani, AD; Genazzani, AR; Grasso, A; Petraglia, F; Volpe, A	1
Campanini, D; Facchinetti, F; Genazzani, AR; Grasso, A; Petraglia, F; Volpe, A	1
Arsoba, J; Dubrawski, W; Radowicki, S	1
Al Azzawi, F; Hart, DM; Lindsay, R; Parkin, DE; Smith, D	1
Abdalla, HI; Beastall, GH; Hart, DM; Lindsay, R	1
Fraser, IS	1
Davidson, JF; McEwan, HP; Richards, A; Walker, ID; Yates, R	1

Reviews

36 review(s) available for tibolone and Menopause

Article	Year
Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature. Medicina (Kaunas, Lithuania), 2019, Aug-14, Volume: 55, Issue:8 Topics: Endometriosis; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Retrospective Studies	2019
Tibolone as Hormonal Therapy and Neuroprotective Agent. Trends in endocrinology and metabolism: TEM, 2020, Volume: 31, Issue:10 Topics: Brain; Estrogen Receptor Modulators; Female; Humans; Menopause; Neuroprotective Agents; Norpregnenes	2020
Hormone therapy for female sexual function during perimenopause and postmenopause: a Cochrane review. Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:2 Topics: Databases, Factual; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Norpregnenes; Perimenopause; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological	2014
Advances in pharmacotherapy for treating female sexual dysfunction. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:6 Topics: Buspirone; Clinical Trials, Phase III as Topic; Estrogens; Female; Humans; Menopause; Norpregnenes; Piperazines; Purines; Selective Estrogen Receptor Modulators; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfonamides; Tamoxifen; Testosterone	2015
Update on management of genitourinary syndrome of menopause: A practical guide. Maturitas, 2015, Volume: 82, Issue:3 Topics: Atrophy; Complementary Therapies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Laser Therapy; Menopause; Norpregnenes; Quality of Life; Selective Estrogen Receptor Modulators; Sexuality; Syndrome; Tamoxifen; Vagina; Vulva	2015
[Hormones and mammographic breast density]. Journal de radiologie, 2008, Volume: 89, Issue:9 Pt 2 Topics: Adult; Aged; Biopsy; Breast; Breast Neoplasms; Contraceptive Agents, Female; Diagnosis, Differential; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Mammography; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity; Tamoxifen	2008
Hot flushes: are there effective alternatives to estrogen? Menopause international, 2010, Volume: 16, Issue:2 Topics: Acupuncture Therapy; Amines; Cimicifuga; Clonidine; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Exercise; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; New Zealand; Norpregnenes; Phytoestrogens; Progesterone; Selective Serotonin Reuptake Inhibitors; Skin; United Kingdom; United States; Vitamin E	2010
Menopause perspectives and treatment of Asian women. Seminars in reproductive medicine, 2010, Volume: 28, Issue:5 Topics: Aged; Asia; Female; Hormone Replacement Therapy; Humans; Life Style; Menopause; Middle Aged; Musculoskeletal Physiological Phenomena; Musculoskeletal System; Norpregnenes; Sleep Initiation and Maintenance Disorders; Women's Health	2010
[Tibolone]. Presse medicale (Paris, France : 1983), 2002, Sep-07, Volume: 31, Issue:28 Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors	2002
Sexuality in the climacteric years. Maturitas, 2002, Aug-30, Volume: 43 Suppl 1 Topics: Aging; Androgen Antagonists; Androgens; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Sexuality	2002
Hormone replacement therapy in women with a history of breast cancer. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Quality of Life; Risk Factors; Selective Estrogen Receptor Modulators	2002
Menopause: new therapies. The Medical journal of Australia, 2003, Jun-16, Volume: 178, Issue:12 Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Intravaginal; Administration, Oral; Climacteric; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Middle Aged; Norpregnenes; Selective Estrogen Receptor Modulators	2003
Tibolone: a unique version of hormone replacement therapy. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:5 Topics: Breast Neoplasms; Cardiovascular System; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Thromboembolism	2004
[Alternatives to hormone replacement therapy for menopause: an epidemiological evaluation]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2004, Volume: 33, Issue:3 Topics: Climacteric; Estrogen Replacement Therapy; Female; Humans; Isoflavones; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators	2004
Menopausal symptoms. Clinical evidence, 2003, Issue:10 Topics: Clonidine; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins	2003
Menopausal symptoms. Clinical evidence, 2004, Issue:11 Topics: Clonidine; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins	2004
[Menopausal hormonal therapies: impact on mammographic breast density]. Journal de radiologie, 2004, Volume: 85, Issue:10 Pt 1 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mammography; Mass Screening; Menopause; Norpregnenes; Raloxifene Hydrochloride	2004
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications. Treatments in endocrinology, 2004, Volume: 3, Issue:2 Topics: Aging; Animals; Arteriosclerosis; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen	2004
Hormone replacement therapy--differing guidelines. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2005, Volume: 95, Issue:4 Topics: Contraindications; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Practice Guidelines as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Menopausal symptoms. Clinical evidence, 2005, Issue:13 Topics: Drug Therapy, Combination; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins	2005
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations. Drug safety, 2005, Volume: 28, Issue:12 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2005
[Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects]. Ugeskrift for laeger, 2006, Feb-06, Volume: 168, Issue:6 Topics: Adult; Androgens; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Incidence; Libido; Menopause; Middle Aged; Norpregnenes; Phosphodiesterase Inhibitors; Piperazines; Postmenopause; Purines; Risk Factors; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Testosterone	2006
Hormone therapy in the WHI era. The Australian & New Zealand journal of obstetrics & gynaecology, 2006, Volume: 46, Issue:2 Topics: Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Forecasting; Humans; Menopause; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk Assessment; Thromboembolism; Victoria; Women's Health	2006
Hormone replacement therapy in women with past history of endometriosis. Climacteric : the journal of the International Menopause Society, 2006, Volume: 9, Issue:5 Topics: Adult; Aged; Endometrial Neoplasms; Endometriosis; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Menopause; Middle Aged; Norpregnenes; Risk Factors	2006
Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Danish medical bulletin, 2006, Volume: 53, Issue:3 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Androgen Antagonists; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Middle Aged; Norpregnenes; Perimenopause; Piperazines; Purines; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Testosterone; Vagina	2006
Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:1 Topics: Antidepressive Agents; Breast Neoplasms; Estrogen Receptor Modulators; Female; Histamine H1 Antagonists; Hot Flashes; Humans; Menopause; Norpregnenes	2007
[Aging and sexuality in women]. Minerva ginecologica, 2007, Volume: 59, Issue:3 Topics: Aging; Arousal; Counseling; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Female; Humans; Libido; Life Style; Menopause; Norpregnenes; Personality; Sexual Behavior; Sexual Dysfunctions, Psychological; Testosterone; Treatment Outcome	2007
Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovascular drug reviews, 2007,Summer, Volume: 25, Issue:2 Topics: Animals; Atherosclerosis; Blood Coagulation; Cardiovascular System; Coronary Disease; Estrogen Receptor Modulators; Female; Humans; Menopause; Middle Aged; Norpregnenes; Tunica Intima	2007
Tibolone: the way to beat many a postmenopausal ailments. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:6 Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2008
Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Clinical interventions in aging, 2008, Volume: 3, Issue:1 Topics: Affect; Androgens; Cognition; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Norpregnenes; Progestins; Testosterone	2008
Tibolone: a review. Maturitas, 1998, Nov-16, Volume: 30, Issue:3 Topics: Anabolic Agents; Bone Density; Breast; Female; Hemodynamics; Hormone Replacement Therapy; Humans; Lipids; Menopause; Norpregnenes; Randomized Controlled Trials as Topic; Uterus	1998
"Extracts from "Clinical evidence": Menopausal symptoms. BMJ (Clinical research ed.), 2000, Dec-16, Volume: 321, Issue:7275 Topics: Estrogens; Female; Female Urogenital Diseases; Humans; Menopause; Middle Aged; Norpregnenes; Progestins; Testosterone	2000
[The concept of selective action steroids]. Gynecologie, obstetrique & fertilite, 2000, Volume: 28, Issue:12 Topics: Anabolic Agents; Blood Glucose; Bone and Bones; Cardiovascular System; Climacteric; Endometrium; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Thrombosis	2000
Tibolone: new type of hormone replacement. Harvard women's health watch, 2001, Volume: 9, Issue:5 Topics: Anabolic Agents; Bone Density; Cholesterol, HDL; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Research	2001
Development and present state of hormone replacement therapy. International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:10 Topics: Anabolic Agents; Androgens; Climacteric; Estrogen Replacement Therapy; Female; Humans; Menopause; Norpregnenes; Progestins	1991
Tibolone (Livial)--a new steroid for the menopause. Drug and therapeutics bulletin, 1991, Sep-30, Volume: 29, Issue:20 Topics: Female; Half-Life; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal	1991

Trials

38 trial(s) available for tibolone and Menopause

Article	Year
Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone. Journal of affective disorders, 2018, 08-15, Volume: 236 Topics: Administration, Oral; Adult; Affect; Antidepressive Agents; Depression; Double-Blind Method; Estrogen Receptor Modulators; Female; Humans; Menopause; Middle Aged; Norpregnenes; Treatment Outcome	2018
Menopausal hormone therapy use in 17 European countries during the last decade. Maturitas, 2014, Volume: 79, Issue:3 Topics: Aged; Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Europe; Female; Global Health; Humans; Menopause; Middle Aged; Norpregnenes; Progestins; Pulmonary Embolism; Risk Factors; Stroke	2014
Changes in serum calcium and vitamin D₃ levels after tibolone treatment and their correlations with health-related quality of life. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2015, Volume: 128, Issue:2 Topics: Adult; Calcium; Cholecalciferol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; India; Menopause; Middle Aged; Norpregnenes; Prospective Studies; Quality of Life	2015
Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause. Gynecologic and obstetric investigation, 2009, Volume: 68, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Blood Coagulation Factors; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Factor VII; Female; Fibrinolysis; Follow-Up Studies; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies	2009
What have we really learned from 'LIBERATE' trial? Maturitas, 2010, Volume: 66, Issue:1 Topics: Breast Neoplasms; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes	2010
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women. Journal of endocrinological investigation, 2010, Volume: 33, Issue:10 Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners	2010
Effect of tibolone on audiologic functions in menopausal women. Climacteric : the journal of the International Menopause Society, 2011, Volume: 14, Issue:2 Topics: Adult; Androgen Antagonists; Case-Control Studies; Female; Hearing; Humans; Menopause; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies	2011
Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:1 Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Estrogen Receptor Modulators; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Norpregnenes; Treatment Outcome; Vasomotor System	2012
Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28, Issue:6 Topics: Administration, Oral; Adult; Double-Blind Method; Endometrium; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Organ Size; Placebos; Treatment Outcome; Ultrasonography	2012
Hearing levels in menopausal women and the effect of tibolone on audiological functions. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2012, Volume: 32, Issue:3 Topics: Audiometry; Estrogen Receptor Modulators; Female; Hearing; Hearing Loss, Sensorineural; Humans; Menopause; Norpregnenes; Postmenopause; Premenopause; Single-Blind Method	2012
[The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2003,Summer, Volume: 14, Issue:2 Topics: Anxiety; Depression; Estradiol; Estrogen Replacement Therapy; Female; Humans; Manifest Anxiety Scale; Menopause; Middle Aged; Norpregnenes; Treatment Outcome	2003
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. Human reproduction (Oxford, England), 2003, Volume: 18, Issue:8 Topics: Adipose Tissue; Alkaline Phosphatase; Body Composition; Bone and Bones; Bone Density; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteocalcin; Peptides; Prospective Studies; Thinness	2003
The role of hormone replacement therapy in endometrial polyp formation. Maturitas, 2005, Mar-14, Volume: 50, Issue:3 Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norpregnenes; Obesity; Polyps; Prospective Studies; Recurrence; Regression Analysis	2005
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:2 Topics: Aged; Breast; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Mammography; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Testosterone	2005
Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 91, Issue:1 Topics: Administration, Cutaneous; Anxiety; Depression; Double-Blind Method; Estradiol Congeners; Estrogen Receptor Modulators; Female; Humans; Menopause; Norpregnenes; Prospective Studies	2005
Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten year experience. Minerva ginecologica, 2006, Volume: 58, Issue:4 Topics: Aged; Estrogen Receptor Modulators; Female; Humans; Menopause; Middle Aged; Norpregnenes; Patient Compliance; Prospective Studies; Time Factors	2006
The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:9 Topics: Cataract; Estrogens; Female; Hormone Replacement Therapy; Humans; Intraocular Pressure; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Tears	2006
Comparison of the effects of tibolone and estrogen therapy on hemostasis in surgical menopause: a randomized, double-blind, placebo-controlled study. Fertility and sterility, 2007, Volume: 87, Issue:4 Topics: Antithrombin III; Blood Coagulation Factors; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hemostasis; Humans; Hysterectomy; Lipoprotein(a); Menopause; Middle Aged; Norpregnenes; Partial Thromboplastin Time; Prospective Studies; Salpingostomy; Venous Thrombosis	2007
Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas, 2007, Sep-20, Volume: 58, Issue:1 Topics: Adult; Asian People; China; Cimicifuga; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Metrorrhagia; Middle Aged; Norpregnenes; Odds Ratio; Phytoestrogens; Phytotherapy; Plant Extracts; Statistics, Nonparametric	2007
Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results. The Journal of reproductive medicine, 2007, Volume: 52, Issue:12 Topics: Adult; Calcium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norpregnenes; Ovariectomy; Prospective Studies; Thyroid Gland; Thyrotropin; Thyroxine; Time Factors; Triiodothyronine	2007
Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients. Archives of gynecology, 1983, Volume: 234, Issue:1 Topics: Aged; Climacteric; Double-Blind Method; Female; Humans; Menopause; Middle Aged; Norpregnenes; Placebos	1983
The incidence of vaginal bleeding with tibolone treatment. British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:1 Topics: Anabolic Agents; Female; Humans; Menopause; Middle Aged; Norpregnenes; Prospective Studies; Uterine Hemorrhage	1994
Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women. Acta endocrinologica, 1993, Volume: 128, Issue:3 Topics: Anabolic Agents; Cholesterol; Female; Humans; Lipoprotein(a); Menopause; Middle Aged; Norpregnenes; Prospective Studies; Time Factors; Triglycerides	1993
Tibolone in the treatment of psychosomatic symptoms in menopause. Clinical and experimental obstetrics & gynecology, 1997, Volume: 24, Issue:3 Topics: Anabolic Agents; Cohort Studies; Female; Humans; Menopause; Middle Aged; Norpregnenes; Psychophysiologic Disorders	1997
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT. Maturitas, 1998, Jun-17, Volume: 29, Issue:3 Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms	1998
A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. British journal of obstetrics and gynaecology, 1998, Volume: 105, Issue:8 Topics: Anabolic Agents; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progesterone Congeners; Sexual Behavior; Sweating; Uterine Hemorrhage; Vaginal Diseases	1998
[The effects of menopausal replacement therapy in women with uterine myomas]. Minerva ginecologica, 1999, Volume: 51, Issue:11 Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms	1999
Lipid effects, effectiveness and acceptability of tibolone versus transdermic 17 beta-estradiol for hormonal replacement therapy in women with surgical menopause. Maturitas, 2000, Nov-30, Volume: 37, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Adult; Anabolic Agents; Cholesterol; Estradiol; Female; Hormone Replacement Therapy; Humans; Hysterectomy; Menopause; Middle Aged; Norpregnenes; Ovariectomy; Patient Compliance; Prospective Studies; Triglycerides	2000
The influence of tibolone on quality of life in postmenopausal women. Maturitas, 2002, Jan-30, Volume: 41, Issue:1 Topics: Anabolic Agents; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Quality of Life; Surveys and Questionnaires; Treatment Outcome	2002
Effect of renal impairment on the pharmacokinetics of a single oral dose of tibolone 2.5 mg in early postmenopausal women. Pharmacotherapy, 2002, Volume: 22, Issue:2 Topics: Aged; Area Under Curve; Estrogen Receptor Modulators; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Menopause; Middle Aged; Norpregnenes; Renal Insufficiency	2002
Short-term effects of Org OD 14 and 17 beta-oestradiol on bone and lipid metabolism in early post-menopausal women. Maturitas, 1991, Volume: 13, Issue:2 Topics: Anabolic Agents; Bone and Bones; Calcium; Carbohydrates; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Menopause; Norpregnenes; Phosphates	1991
Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women. Gynecologic and obstetric investigation, 1988, Volume: 26, Issue:2 Topics: Adult; beta-Endorphin; beta-Lipotropin; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norpregnenes	1988
Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women. Maturitas, 1987, Volume: Suppl 1 Topics: Adult; Animals; beta-Endorphin; beta-Lipotropin; Castration; Endorphins; Female; Humans; Menopause; Middle Aged; Norpregnenes; Pituitary Gland; Rats; Rats, Inbred Strains	1987
Benefits and risks of different hormonal replacement therapies in post-menopausal women. Maturitas, 1986, Volume: 8, Issue:4 Topics: Adult; Cholesterol; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Endometrium; Estradiol; Estriol; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norpregnenes	1986
[Tibolone (Livial) in the treatment of disorders of the postmenopausal period (preliminary report)]. Ginekologia polska, 1988, Volume: 59, Issue:11 Topics: Cardiovascular Diseases; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Nervous System Diseases; Neurocognitive Disorders; Neurotic Disorders; Norpregnenes	1988
Effects of long-term Org OD 14 administration on blood coagulation in climacteric women. Maturitas, 1987, Volume: 9, Issue:1 Topics: Blood Coagulation; Blood Coagulation Tests; Clinical Trials as Topic; Factor VII; Factor X; Female; Humans; Menopause; Middle Aged; Norpregnenes; Random Allocation; Time Factors	1987
Organon OD 14 (tibolone) and menopausal dynamic hormone profiles. Maturitas, 1986, Volume: 8, Issue:1 Topics: Anabolic Agents; Female; Humans; Menopause; Norpregnenes; Pituitary Hormones; Sex Hormone-Binding Globulin; Testosterone	1986
The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal women. Thrombosis and haemostasis, 1985, Jun-24, Volume: 53, Issue:3 Topics: Adult; Aged; Alanine Transaminase; Anabolic Agents; Aspartate Aminotransferases; Bilirubin; Blood Cell Count; Blood Coagulation Tests; Climacteric; Clinical Trials as Topic; Female; Fibrinolysis; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Lipids; Lipoproteins; Liver Function Tests; Menopause; Middle Aged; Norpregnenes; Placebos; Platelet Count; Triglycerides	1985

Other Studies

46 other study(ies) available for tibolone and Menopause

Article	Year
Tibolon - the only one member of STEARs group. Casopis lekaru ceskych, 2019,Summer, Volume: 158, Issue:3-4 Topics: Breast Neoplasms; Climate; Estrogen Receptor Modulators; Estrogens; Female; Humans; Menopause; Norpregnenes; Osteoporosis; Progestins	2019
[Reasons for abandonment of hormone replacement therapy with tibolone in menopausal women]. Ginecologia y obstetricia de Mexico, 2013, Volume: 81, Issue:10 Topics: Adult; Cross-Sectional Studies; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Medication Adherence; Menopause; Mexico; Middle Aged; Norpregnenes	2013
Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries. Maturitas, 2016, Volume: 84 Topics: Aged; Breast Neoplasms; Commerce; Databases, Pharmaceutical; Estrogen Receptor Modulators; Europe; Female; Hormone Replacement Therapy; Humans; Incidence; Menopause; Middle Aged; Norpregnenes	2016
Tibolone-induced acute hepatitis: Well-known drug, little-known complication. Gastroenterologia y hepatologia, 2017, Volume: 40, Issue:4 Topics: Biopsy; Chemical and Drug Induced Liver Injury; Estrogen Receptor Modulators; Female; Humans; Menopause; Middle Aged; Norpregnenes	2017
[Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014]. Medicina clinica, 2016, Oct-07, Volume: 147, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Cross-Sectional Studies; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Norpregnenes; Practice Patterns, Physicians'; Progestins; Spain	2016
Hormone replacement therapy use and the risk of stroke. Maturitas, 2008, Dec-20, Volume: 61, Issue:4 Topics: Aged; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Middle Aged; Norpregnenes; Progestins; Risk Factors; Stroke	2008
Tibolone: the risk is too high. The Lancet. Oncology, 2009, Volume: 10, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Risk	2009
The use of estrogen therapy in women's sexual functioning (CME). The journal of sexual medicine, 2009, Volume: 6, Issue:3 Topics: Administration, Cutaneous; Aged; Atrophy; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norpregnenes; Sexual Dysfunction, Physiological; Vagina; Vasoconstriction	2009
[Prevalence of use of hormone replacement therapy in women participating in a breast cancer screening program]. Medicina clinica, 2010, Apr-10, Volume: 134, Issue:10 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Confidence Intervals; Data Interpretation, Statistical; Estrogen Replacement Therapy; Estrogens; Female; Health Surveys; Hormone Replacement Therapy; Humans; Mass Screening; Menopause; Middle Aged; Norpregnenes; Postmenopause; Prevalence; Progestins; Socioeconomic Factors; Spain; Surveys and Questionnaires	2010
Effects of menopause and tibolone on different cardiovascular biomarkers in healthy women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2011, Volume: 27, Issue:3 Topics: Antioxidants; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Physiological Phenomena; Cholesterol; Estrogen Receptor Modulators; Female; Humans; Interleukin-6; Menopause; Middle Aged; Norpregnenes; Triglycerides; Tumor Necrosis Factor-alpha	2011
EMAS position statement: Managing the menopause in women with a past history of endometriosis. Maturitas, 2010, Volume: 67, Issue:1 Topics: Endometriosis; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Menopause; Menopause, Premature; Norpregnenes; Recurrence	2010
Practice observed. Menopause international, 2010, Volume: 16, Issue:3 Topics: Adult; Amenorrhea; Bone Density; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mastitis; Menopause; Norpregnenes; Quality of Life; Sexual Behavior; Smoking Cessation	2010
Discrepancy in improvement of hearing loss between left and right ears after postmenopausal hormone therapy. Medical hypotheses, 2011, Volume: 76, Issue:3 Topics: Estrogen Receptor alpha; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Functional Laterality; Hearing; Hearing Loss; Humans; Menopause; Middle Aged; Norpregnenes; Receptors, Estrogen	2011
Tibolone and breast cancer. Prescrire international, 2010, Volume: 19, Issue:111 Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Norpregnenes	2010
Visceral adiposity after tibolone use. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 115, Issue:2 Topics: Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Estrogen Receptor Modulators; Female; Humans; Intra-Abdominal Fat; Menopause; Middle Aged; Norpregnenes; Prospective Studies; Waist Circumference	2011
Hormonal replacement therapy in ovarian cancer survivors: a survey among Greek gynecologists. European journal of gynaecological oncology, 2011, Volume: 32, Issue:5 Topics: Antineoplastic Agents, Hormonal; Attitude of Health Personnel; Diphosphonates; Estrogens; Female; Greece; Gynecology; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Ovarian Neoplasms; Phytoestrogens; Prescriptions; Progestins; Surveys and Questionnaires	2011
What happened to WHI: menopausal hormonal therapy in 2012. Clinical obstetrics and gynecology, 2012, Volume: 55, Issue:3 Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina	2012
[Treatments "substitute" to Hormonal Replacement Therapy of menopause]. Presse medicale (Paris, France : 1983), 2002, Sep-07, Volume: 31, Issue:28 Topics: Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Selective Estrogen Receptor Modulators	2002
Tibolone. Acta obstetricia et gynecologica Scandinavica, 2004, Volume: 83, Issue:6 Topics: Abnormalities, Drug-Induced; Adult; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Infant, Newborn; Menopause; Norpregnenes; Pregnancy	2004
Tibolone: how does its mechanism of action translate into clinical effects. Maturitas, 2004, Aug-30, Volume: 48 Suppl 1 Topics: Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Randomized Controlled Trials as Topic; Receptors, Estrogen; Selective Estrogen Receptor Modulators	2004
Multisystem evaluations of the long-term effects of tibolone on postmenopausal monkeys. Maturitas, 2004, Aug-30, Volume: 48 Suppl 1 Topics: Animals; Coronary Vessels; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Longitudinal Studies; Lumbar Vertebrae; Macaca fascicularis; Mammary Glands, Animal; Menopause; Models, Animal; Norpregnenes; Ovariectomy; Random Allocation; Selective Estrogen Receptor Modulators; Uterus	2004
Effects of tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: an observational follow-up study. The Australian & New Zealand journal of obstetrics & gynaecology, 2005, Volume: 45, Issue:1 Topics: Anxiety; Cognition; Depression; Estrogen Receptor Modulators; Female; Health Status Indicators; Humans; Menopause; Middle Aged; Norpregnenes; Quality of Life	2005
Progestins and recurrence in breast cancer survivors. Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7 Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Survivors; Treatment Outcome	2005
Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas, 2005, May-16, Volume: 51, Issue:1 Topics: Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Norpregnenes; Randomized Controlled Trials as Topic; Sexuality	2005
Effects of menopause and tibolone on antioxidants in postmenopausal women. Annals of clinical biochemistry, 2005, Volume: 42, Issue:Pt 3 Topics: Adult; alpha-Tocopherol; Antioxidants; Case-Control Studies; Ceruloplasmin; Erythrocytes; Estrogen Receptor Modulators; Female; Glutathione; Humans; Lipid Peroxidation; Malondialdehyde; Menopause; Middle Aged; Norpregnenes; Oxidative Stress; Postmenopause; Premenopause; Sulfhydryl Compounds	2005
Cyclooxygenase-2 expression in endometrial polyps during menopause. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 21, Issue:6 Topics: Cyclooxygenase 2; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Ki-67 Antigen; Menopause; Norpregnenes; Polyps; Tamoxifen; Uterine Diseases	2005
Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms. The American journal of medicine, 2005, Dec-19, Volume: 118 Suppl 12B Topics: Androgens; Dehydroepiandrosterone; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Progestins; Testosterone	2005
Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause. Climacteric : the journal of the International Menopause Society, 2006, Volume: 9, Issue:1 Topics: Carotid Arteries; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Prospective Studies; Pulsatile Flow; Time Factors; Treatment Outcome; Triglycerides; Tunica Intima; Vascular Resistance; Vertebral Artery	2006
Tibolone is not used as a first-line therapy: implications for the Million Women Study analysis. The journal of the British Menopause Society, 2006, Volume: 12, Issue:2 Topics: England; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Medical Records; Menopause; Norpregnenes; Retrospective Studies	2006
Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys. Journal of neuroendocrinology, 2006, Volume: 18, Issue:9 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Dopamine; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Hormones; Hydroxyindoleacetic Acid; Macaca fascicularis; Medroxyprogesterone Acetate; Menopause; Norepinephrine; Norpregnenes; Ovariectomy; Serotonin	2006
Effectiveness of tibolone on the reduction of menopausal problems--a Bayesian semi-parametric interpretation. Statistics in medicine, 2007, Mar-15, Volume: 26, Issue:6 Topics: Adult; Aged; Bayes Theorem; Data Interpretation, Statistical; Estrogen Receptor Modulators; Female; Humans; India; Menopause; Middle Aged; Norpregnenes; Statistics, Nonparametric; Treatment Outcome	2007
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. European journal of clinical pharmacology, 2007, Volume: 63, Issue:9 Topics: Adult; Aged; Bone Density Conservation Agents; Data Collection; Diphosphonates; Drug Prescriptions; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'; Reproducibility of Results; Risk Assessment; Time Factors; United Kingdom	2007
Effects of tibolone on health-related quality of life in menopausal women. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007, Volume: 99, Issue:1 Topics: Adult; Estrogen Receptor Modulators; Female; Follow-Up Studies; Health Status; Humans; Hysterectomy; Menopause; Middle Aged; Norpregnenes; Ovariectomy; Prospective Studies; Quality of Life; Severity of Illness Index; Time Factors	2007
[Review of pharmacological treatment of the menopause]. Atencion primaria, 2007, Volume: 39, Issue:8 Topics: Cross-Over Studies; Drug Prescriptions; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Primary Health Care; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spain	2007
Brachial artery responses in menopausal women using tibolone. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 101, Issue:1 Topics: Blood Flow Velocity; Brachial Artery; Estrogen Receptor Modulators; Female; Humans; Menopause; Mexico; Middle Aged; Norpregnenes; Postmenopause; Vascular Resistance	2008
Org OD 14: long-term effects on serum lipoproteins. Maturitas, 1984, Volume: 6, Issue:3 Topics: Cholesterol; Female; Humans; Lipoproteins; Menopause; Middle Aged; Norpregnenes; Osteoporosis; Time Factors; Triglycerides	1984
Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized women. Maturitas, 1984, Volume: 5, Issue:4 Topics: Adult; Biopsy; Castration; Cell Division; Cervix Uteri; Drug Evaluation; Endometrium; Estrogens; Female; Humans; Lynestrenol; Menopause; Middle Aged; Mucus; Norpregnenes; Uterine Hemorrhage; Vagina; Vaginal Smears	1984
Trial of synthetic steroid for preventing postmenopausal osteoporosis. British medical journal, 1980, Aug-09, Volume: 281, Issue:6237 Topics: Anabolic Agents; Body Weight; Female; Humans; Menopause; Norpregnenes; Osteoporosis	1980
Postmenopausal hormone replacement therapy with Tibolone decreases serum lipoprotein(a). European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 1993, Volume: 31, Issue:10 Topics: Anabolic Agents; Estrogen Replacement Therapy; Female; Humans; Lipoprotein(a); Lipoproteins; Menopause; Middle Aged; Norpregnenes	1993
Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy. British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:2 Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Menopause; Middle Aged; Norpregnenes	1994
[A preliminary report on the treatment of climacteric symptoms with Org OD14]. Zhonghua fu chan ke za zhi, 1993, Volume: 28, Issue:9 Topics: Adult; Anabolic Agents; Climacteric; Endometrium; Female; Humans; Menopause; Middle Aged; Norpregnenes	1993
Alternatives to estrogen replacement therapy. Annals of the New York Academy of Sciences, 2000, Volume: 900 Topics: Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Menopause; Norpregnenes; Phytoestrogens; Plant Preparations; Plants; Selective Estrogen Receptor Modulators	2000
Mammographic density changes in postmenopausal women using tibolone therapy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2001, Volume: 74, Issue:1 Topics: Anabolic Agents; Breast; Female; Hormone Replacement Therapy; Humans; Mammography; Medical Records; Menopause; Middle Aged; Norpregnenes; Retrospective Studies	2001
Org OD 14 and the endometrium. Maturitas, 1991, Volume: 13, Issue:3 Topics: Endometrium; Female; Humans; Menopause; Middle Aged; Norpregnenes; Time Factors	1991
Long-term effects of Org OD 14 on lipid metabolism in post-menopausal women. Maturitas, 1990, Volume: 12, Issue:1 Topics: Anabolic Agents; Female; Humans; Lipid Metabolism; Menopause; Middle Aged; Norpregnenes; Time Factors	1990
A review of the role of progestogens in hormonal replacement therapy: influence on bleeding patterns. Maturitas, 1986, Volume: 8, Issue:2 Topics: Biomechanical Phenomena; Drug Combinations; Drug Therapy, Combination; Endometrium; Estrogens; Female; Humans; Menopause; Menstruation; Middle Aged; Norpregnenes; Progestins	1986